Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |